Crescent Biopharma is illuminating a brighter future for cancer patients with potentially best-in-class therapies to transform solid tumor treatment.
Our pipeline of novel, precision-engineered biologics originated at Paragon Therapeutics, a biotechnology company founded by Fairmount. Crescent is the fifth company launched to advance assets discovered
